title: [Usage of urine FT levels for medication compliance in head and neck cancer with administration of UFT].
authors.forename: H
authors.initials: H
authors.lastname: Ogasawara
authors.forename: M
authors.initials: M
authors.lastname: Horiuchi
authors.forename: M
authors.initials: M
authors.lastname: Tsukuda
authors.forename: S
authors.initials: S
authors.lastname: Kaneko
authors.forename: S
authors.initials: S
authors.lastname: Komiyama
authors.forename: M
authors.initials: M
authors.lastname: Sugita
authors.forename: H
authors.initials: H
authors.lastname: Miyake
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000652:urine*; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000652:urine; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000008:administration & dosage / Q000652:urine; D014498:Uracil / Q000008:administration & dosage / Q000652:urine
chemical_list: D005641:Tegafur; D014498:Uracil; D005472:Fluorouracil